Zlotecki R A, Jung L A, Vauthey J N, Vogel S B, Mendenhall W M
Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, USA.
Radiat Oncol Investig. 1998;6(5):240-7. doi: 10.1002/(SICI)1520-6823(1998)6:5<240::AID-ROI6>3.0.CO;2-R.
Forty-seven patients were treated for carcinoma of the extrahepatic biliary tract between 1962 and 1993: 17 by surgery alone, 20 by surgery and postoperative radiotherapy, and 10 with radiotherapy alone. Initial operations included gross total resection (17 patients), simple cholecystectomy (6 patients), subtotal resection (11 patients), biopsy (3 patients), and percutaneous decompression (10 patients). External-beam radiotherapy (30-60 Gy) was administered to 30 patients: 10 after gross total resection or simple cholecystectomy, 10 after subtotal resection or surgical biopsy, and 10 after percutaneous decompression. Overall survival was 26% at 3 years and 15% at 5 years. The 5-year survival rate was 15% for 17 patients treated by surgery alone and 14% for 30 patients treated with radiotherapy alone or following surgery. After gross total resection, median survival time was 26.1 months for 9 patients treated by surgery alone vs. 43.4 months for 8 patients who received postoperative radiotherapy. After gross total resection or cholecystectomy, 5-year survival rates were 19% for surgery alone and 35% for surgery and postoperative radiotherapy (P=.07). Median survival for 10 patients treated by radiation therapy alone after percutaneous decompression was 6.4 months. Postoperative adjuvant radiotherapy was well tolerated and may improve local-regional control after gross total resection.
1962年至1993年间,47例患者接受了肝外胆管癌治疗:17例仅接受手术治疗,20例接受手术及术后放疗,10例仅接受放疗。初始手术包括根治性切除(17例患者)、单纯胆囊切除术(6例患者)、次全切除(11例患者)、活检(3例患者)以及经皮减压(10例患者)。30例患者接受了外照射放疗(30 - 60 Gy):10例在根治性切除或单纯胆囊切除术后接受放疗,10例在次全切除或手术活检后接受放疗,10例在经皮减压后接受放疗。3年总生存率为26%,5年总生存率为15%。仅接受手术治疗的17例患者5年生存率为15%,仅接受放疗或术后接受放疗的30例患者5年生存率为14%。根治性切除后,仅接受手术治疗的9例患者中位生存时间为26.1个月,而接受术后放疗的8例患者中位生存时间为43.4个月。根治性切除或胆囊切除术后,仅手术治疗的5年生存率为19%,手术及术后放疗的5年生存率为35%(P = 0.07)。经皮减压后仅接受放疗的10例患者中位生存时间为6.4个月。术后辅助放疗耐受性良好,可能改善根治性切除后的局部区域控制。